Monitoring

Active surveillance instead of immediate treatment may be appropriate for many men diagnosed with prostate cancer especially in the early stages¹⁰. GE Healthcare's technology can help monitor the patient and quickly identify any abnormal responses. It can also help characterise nodules or abnormalities with greater accuracy.

Contact Us
Subscribe to Smartmail
1800 659 465 (AUS)
0800 659 465 (NZ)

Products

SIGNA™ PET/MR with QuantWorks – 60cm
Introducing SIGNA™ PET/MR with QuantWorks. Built with pioneering TOF and integrated with a 3.0T MR.
LOGIQ™ E10 Ultrasound Series

Next-generation, leadership ultrasound that adapts to your needs, today and into the future. Choose from a wide array of advanced imaging tools and robust productivity enhancers based on artificial intelligence—all on a scalable platform that lets you configure your system specifically to the needs of your practice.

Take advantage of our most technologically-advanced ultrasound ever to bring fast, precise, consistent imaging to your patients—your way— with the LOGIQ E10 Series.
OEC Elite CFD
The OEC Elite CFD offers stunning image clarity and detail at low dose with enhancements for an easy and efficient experience.
PET/CT
The true potential of PET/CT is its ability to enable a true discovery.

10. Cancer facts and figures 2018 [Internet]. Atlanta, Georgia: The American Cancer Society; 2018 [cited 2 November 2018]. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf

Therapy and Monitoring

Therapy and Monitoring

Products

SIGNA™ PET/MR with QuantWorks – 60cm

LOGIQ™ E10 Ultrasound Series

OEC Elite CFD

PET/CT